Has Kyle Horton-Maser received payments from drug or device companies?

Yes. Drug and device makers reported $12,083 in general payments to Kyle Horton-Maser across 759 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Kyle Horton-Maser did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Kyle Horton-Maser come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Kyle Horton-Maser

Nurse Practitioner · Williamsville, NYNPI 1558754044

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.0% of the total across 759 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 20.6% — the pattern of someone who eats at a lot of different presentations. Among nurse practitioner clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$12,083in general payments, 2019–2025

Across 759 payments — averaging $15.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$2K
Johnson & Johnson$2K
Novartis$947
Sanofi$867
UCB, Inc.$860
E.r. Squibb & Sons, L.L.C.$720
plus $4K from 17 others

What the payments were for

Food & beverage$11,84298%
Education$2412%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	170	$2,485
Johnson & Johnson	99	$2,029
Novartis	152	$947
Sanofi	28	$867
UCB, Inc.	58	$860
E.r. Squibb & Sons, L.L.C.	34	$720
Pfizer	35	$629
Amgen	25	$617
Lilly USA, LLC	23	$534
Regeneron Healthcare Solutions, Inc.	22	$508
Dermavant Sciences, Inc.	34	$427
Incyte Corporation	19	$397
LEO Pharma Inc.	15	$281
Galderma Laboratories, L.p.	17	$187
Boehringer Ingelheim	9	$168
Organon	6	$154
Sandoz	3	$55
Sun Pharmaceutical Industries Inc.	3	$51
Botanix SB Inc	2	$43
VYNE Pharmaceuticals Inc.	2	$41
Fresenius Kabi USA, LLC	1	$30
Chiesi USA, Inc.	1	$30
Blueprint Medicines Corporation	1	$24

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

VTAMA$124
EBGLYSS$100

How this compares

$12,083 in reported general payments places this provider in the 95th percentile of 4,112 nurse practitioner providers in New York.

See all nurse practitioner providers in New York →

Medicare billing

Part B allowed, 2024

$41,805

Medicare patients

229

Services billed

737

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Clindamycin Phosphate	78	$3,841
Ketoconazole	115	$3,570
Hydrocortisone	136	$2,853
Metronidazole	33	$2,737
Calcipotriene	12	$1,753
Fluocinonide	41	$1,678
Fluorouracil	24	$1,657
Clobetasol Propionate	52	$1,637
Triamcinolone Acetonide	83	$1,339
Doxycycline Hyclate	18	$478
NyamycNystatin	11	$449
Clotrimazole	19	$429
Minocycline Hcl	24	$303
Spironolactone	37	$282
CiclopiroxCiclopirox Olamine	14	$253

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Williamsville

Susan KreppelWilliamsville$67K
Julia GajewskiWilliamsville$16K
Patricia McGoldrickNew York$202K
Michelle DartSyracuse$95K
Kerry AhernEast Syracuse$55K
Valerie StanleyAlbany$55K
Jodi LogerfoNew York$48K
Grace WlasowiczRochester$41K
Melissa LevinElmhurst$34K
Carla JungquistCanandaigua$28K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →